Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARIUSZ W GADULA

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1548292832
CMS profile
161177
Location
OAK LAWN, IL

General Payments · PY2018–2024

$6,166.56

  • Reported across 373 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$316.49

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $316.49 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $177.15 8
Amgen Inc. $61.27 3
Inspire Medical Systems, Inc. $37.35 2
Xeris Pharmaceuticals, Inc. $20.72 1
Novo Nordisk AS $20.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,436.16 101
PY2019 $1,446.42 92
PY2020 $907.98 56
PY2021 $1,016.19 59
PY2022 $612.44 30
PY2023 $430.88 20
PY2024 $316.49 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $15.13 03/18/2024 Food and Beverage Undisputed 01/23/2026 1111579229 CMS
Amgen Inc. $21.13 05/20/2024 Food and Beverage Undisputed 01/23/2026 1111579231 CMS
Amgen Inc. $25.01 06/03/2024 Food and Beverage Undisputed 01/23/2026 1111579233 CMS
Inspire Medical Systems, Inc. $22.04 01/11/2024 Food and Beverage Undisputed 01/23/2026 1148054944 CMS
Inspire Medical Systems, Inc. $15.31 08/13/2024 Food and Beverage Undisputed 01/23/2026 1148054946 CMS
Novo Nordisk Inc $20.00 05/02/2024 Food and Beverage Undisputed 01/23/2026 1097570554 CMS
PFIZER INC. $26.32 02/16/2024 Food and Beverage Undisputed 01/23/2026 1131058729 CMS
PFIZER INC. $25.64 03/07/2024 Food and Beverage Undisputed 01/23/2026 1131232137 CMS
PFIZER INC. $21.50 03/29/2024 Food and Beverage Undisputed 01/23/2026 1131367372 CMS
PFIZER INC. $22.09 05/03/2024 Food and Beverage Undisputed 01/23/2026 1131506876 CMS
PFIZER INC. $14.64 06/06/2024 Food and Beverage Undisputed 01/23/2026 1131646303 CMS
PFIZER INC. $19.09 06/12/2024 Food and Beverage Undisputed 01/23/2026 1131702611 CMS
PFIZER INC. $25.54 10/03/2024 Food and Beverage Undisputed 01/23/2026 1132105508 CMS
PFIZER INC. $22.33 11/01/2024 Food and Beverage Undisputed 01/23/2026 1131170165 CMS
Xeris Pharmaceuticals, Inc. $20.72 02/15/2024 Food and Beverage Undisputed 01/23/2026 1144604470 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.